In vitro degradation of β-amyloid[25-35] peptide

被引：1

作者：

Jost, K ^{[1
]}

Varga, J ^{[1
]}

Penke, S ^{[1
]}

Zarándi, M ^{[1
]}

机构：

[1] Univ Szeged, Fac Med, Dept Med Chem, H-6720 Szeged, Hungary

来源：

PROTEIN AND PEPTIDE LETTERS | 2001年 / 8卷 / 06期

关键词：

D O I：

10.2174/0929866013409076

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Some amyloid-derived peptides show their toxic effects only after a long "aging" period performed several days at pH 7.4 and 37 degreesC far cluster formation. Our experiments show that long aging of beta -amyloid[25-35] under physiological conditions results in peptide band cleavage between Asn(27) and Lys(28). Relatively short incubation time (24 hours) and absence of Ca2+ ions prevent peptide cleavage and results in good aggregation of beta -amyloids.

引用

页码：423 / 428

页数：6

共 50 条

[31] Amyloid β-peptide(25-35) changes [Ca2+] in hippocampal neurons
Mogensen, HS
Beatty, DM
Morris, SJ
Jorgensen, OS
NEUROREPORT, 1998, 9 (07) : 1553 - 1558
[32] Genistein ameliorated β-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis
Zhao, BL
NEUROBIOLOGY OF AGING, 2004, 25 : S569 - S569
[33] Amyloid Beta-Peptide 25-35 (Aβ25-35) Induces Cytotoxicity via Multiple Mechanisms: Roles of the Inhibition of Glucosylceramide Synthase by Aβ25-35 and Its Protection by D609
Tang, Zhihui
Motoyoshi, Kaisei
Honda, Takuya
Nakamura, Hiroyuki
Murayama, Toshihiko
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (10) : 1419 - 1426
[34] Transferrin neutralization of amyloid β 25-35 cytotoxicity
Giunta, S
Galeazzi, R
Valli, MB
Corder, EH
Galeazzi, L
CLINICA CHIMICA ACTA, 2004, 350 (1-2) : 129 - 136
[35] Effect of Cilostazol on Learning and Memory Impairment Induced by β Amyloid Peptide (25-35) in Mice
Takiguchi, Osanao
Mori, Hiromasa
Nishiyama, Aki
Nabeshima, Toshitaka
Hiramatsu, Masayuki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 88P - 88P
[36] Inhibition of toxicity in the β-amyloid peptide β(25-35) using N-methylated derivatives
Doig, A
Hughes, E
Burke, R
Lu, J
Su, TJ
Heenan, R
NEUROBIOLOGY OF AGING, 2002, 23 (01) : S107 - S108
[37] Effect of beta-Amyloid Peptide Fragment 25-35 on Nonselective Permeability of Mitochondria
E. F. Shevtzova
E. G. Kireeva
S. O. Bachurin
Bulletin of Experimental Biology and Medicine, 2001, 132 : 1173 - 1176
[38] GABA transporter 2 expression in hippocampus after β-amyloid peptide (Aβ25-35) injection
Takagi, Shoko
Nishioka, Kasumi
Ueda, Ryo
Ibi, Daisuke
Mamiya, Takayoshi
Kojima, Ryoji
Hiramatsu, Masayuki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S231 - S231
[39] β-amyloid peptide (25-35) as a tool for in vivo modelling Alzheimer's disease in rats
Stepanichev, MY
Onufriev, MV
Moiseeva, YV
Lazareva, NA
Alessenko, AV
Victorov, IV
Gulyaeva, NV
JOURNAL OF NEUROCHEMISTRY, 2001, 77 : 19 - 19
[40] Interaction of the β amyloid - Aβ(25-35) - peptide with zwitterionic and negatively charged vesicles with and without cholesterol
Singh, Jasmeet
Peric, Miroslav
CHEMISTRY AND PHYSICS OF LIPIDS, 2018, 216 : 39 - 47

← 1 2 3 4 5 →